Brean Murray Carret & Co. Downgrades NuVasive (NUVA) to Hold on Warning; Globus (GMED), Orthofix (OFIX) Benefit
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- Trump threatens to bomb Oman over Iran stance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- L3Harris CEO steps down amid conduct review, shares drop
RBC Capital Downgrades NuVasive (NUVA) to Underperform
October 4, 2012 6:56 AM EDTRBC Capital downgraded NuVasive (NASDAQ: NUVA) from Outperform to Underperform with a price target of $16.00 (from $25.00) after the Q3 warning after the close.
For an analyst... More
BMO Capital Downgrades NuVasive (NUVA) to Underperform after Warning
October 4, 2012 6:54 AM EDTBMO Capital downgraded NuVasive (NASDAQ: NUVA) from Market Perform to Underperform with a price target of $15.00 (from $23.00), after the Q3 warning after the close.
For an... More
NuVasive (NUVA) Guides Q3 Revenues Lower
October 3, 2012 4:07 PM EDTNuVasive, Inc. (NASDAQ: NUVA) announced preliminary unaudited information regarding expected revenue results for the third quarter 2012, which was below its prior views and the Wall Street consensus.
NuVasive anticipates revenue for the third quarter 2012 to be approximately $147 million, which is below the Company's... More
